{"transactions":[{"id":731701,"issuer":{"id":1860,"kind":"organization","name":"Liquidia Corp","symbol":"LQDA"},"owners":[{"id":36706,"kind":"person","name":"Horobin Joanna","position":1,"cik":"0001560959","reported_name":"Horobin Joanna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2026-06-18T20:32:39.000Z","date":"2026-06-16","kind":"grant","planned":false,"acquired":true,"shares":5882,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"The RSUs shall vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the day prior to the Issuer's next annual shareholder meeting following the date of grant."}],"balance_after":39637,"source":{"system":"sec-edgar","filing":"0001104659-26-075784","document":"tm2618309-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1560959/000110465926075784/tm2618309-3_4seq1.xml","form_type":"4"}},{"id":1059048,"issuer":{"id":1860,"kind":"organization","name":"Liquidia Corp","symbol":"LQDA"},"owners":[{"id":36706,"kind":"person","name":"Horobin Joanna","position":1,"cik":"0001560959","reported_name":"Horobin Joanna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-08-21T20:30:15.000Z","date":"2025-08-19","kind":"sale","planned":false,"acquired":false,"shares":5000,"price":27.17,"value":135850.0,"ownership":{"direct":true},"footnotes":[{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Includes 18,396 restricted stock units granted to the Reporting Person on June 17, 2025, none of which have vested as of the date of this Form 4."}],"balance_after":33755,"source":{"system":"sec-edgar","filing":"0001104659-25-081441","document":"tm2523977-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1560959/000110465925081441/tm2523977-1_4seq1.xml","form_type":"4"}},{"id":1104641,"issuer":{"id":1860,"kind":"organization","name":"Liquidia Corp","symbol":"LQDA"},"owners":[{"id":36706,"kind":"person","name":"Horobin Joanna","position":1,"cik":"0001560959","reported_name":"Horobin Joanna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2025-06-20T20:31:19.000Z","date":"2025-06-17","kind":"grant","planned":false,"acquired":true,"shares":18396,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"The RSUs shall vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the day prior to the Issuer's next annual shareholder meeting following the date of grant."}],"balance_after":38755,"source":{"system":"sec-edgar","filing":"0001104659-25-061188","document":"tm2518541-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1560959/000110465925061188/tm2518541-3_4seq1.xml","form_type":"4"}},{"id":1470383,"issuer":{"id":1860,"kind":"organization","name":"Liquidia Corp","symbol":"LQDA"},"owners":[{"id":36706,"kind":"person","name":"Horobin Joanna","position":1,"cik":"0001560959","reported_name":"Horobin Joanna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-25T01:37:05.000Z","date":"2024-06-20","kind":"grant","planned":false,"acquired":true,"shares":20359,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Restricted stock units (\"RSUs\") convert into common stock on a one-for-one basis."},{"field":"shares","element":"transactionShares","label":"F2","text":"The RSUs shall vest upon the earlier of (i) the one-year anniversary of the date of grant or (ii) the day prior to the Issuer's next annual shareholder meeting following the date of grant."}],"balance_after":20359,"source":{"system":"sec-edgar","filing":"0001104659-24-074470","document":"tm2418154-3_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1560959/000110465924074470/tm2418154-3_4seq1.xml","form_type":"4"}},{"id":1487017,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":36706,"kind":"person","name":"Horobin Joanna","position":1,"cik":"0001560959","reported_name":"Horobin Joanna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2024-06-07T22:36:33.000Z","date":"2024-06-07","kind":"exercise","planned":true,"acquired":false,"shares":8500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated March 8, 2024 adopted by the reporting person."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The shares underlying this stock option vest in forty-eight (48) equal monthly installments following the vesting commencement date of May 16, 2018, subject to the reporting person's continued employment through each vesting date."}],"balance_after":33195,"derivative":{"exercise_price":2.08,"expiration_date":"2029-05-22","underlying":"Common Stock","underlying_shares":8500},"source":{"system":"sec-edgar","filing":"0000950170-24-070966","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000095017024070966/ownership.xml","form_type":"4"}},{"id":1487016,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":36706,"kind":"person","name":"Horobin Joanna","position":1,"cik":"0001560959","reported_name":"Horobin Joanna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-07T22:36:33.000Z","date":"2024-06-07","kind":"sale","planned":true,"acquired":false,"shares":6313,"price":33.1071,"value":209005.1223,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated March 8, 2024 adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $32.88 to $33.39, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0000950170-24-070966","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000095017024070966/ownership.xml","form_type":"4"}},{"id":1487015,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":36706,"kind":"person","name":"Horobin Joanna","position":1,"cik":"0001560959","reported_name":"Horobin Joanna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-07T22:36:33.000Z","date":"2024-06-07","kind":"sale","planned":true,"acquired":false,"shares":2187,"price":32.6451,"value":71394.8337,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated March 8, 2024 adopted by the reporting person."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $31.88 to $32.86, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":6313,"source":{"system":"sec-edgar","filing":"0000950170-24-070966","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000095017024070966/ownership.xml","form_type":"4"}},{"id":1487014,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":36706,"kind":"person","name":"Horobin Joanna","position":1,"cik":"0001560959","reported_name":"Horobin Joanna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2024-06-07T22:36:33.000Z","date":"2024-06-07","kind":"exercise","planned":true,"acquired":true,"shares":8500,"price":2.08,"value":17680.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"These transactions were effected pursuant to a Rule 10b5-1 trading plan dated March 8, 2024 adopted by the reporting person."}],"balance_after":8500,"source":{"system":"sec-edgar","filing":"0000950170-24-070966","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000095017024070966/ownership.xml","form_type":"4"}},{"id":1847555,"issuer":{"id":1860,"kind":"organization","name":"Liquidia Corp","symbol":"LQDA"},"owners":[{"id":36706,"kind":"person","name":"Horobin Joanna","position":1,"cik":"0001560959","reported_name":"Horobin Joanna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2023-06-21T21:00:58.000Z","date":"2023-06-19","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 36 equal monthly installments and will become fully vested on June 19, 2026."}],"balance_after":20000,"derivative":{"exercise_price":8.63,"exercise_date":"2026-06-19","expiration_date":"2033-06-19","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001104659-23-073392","document":"tm2317720-6_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1560959/000110465923073392/tm2317720-6_4seq1.xml","form_type":"4"}},{"id":1849731,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":36706,"kind":"person","name":"Horobin Joanna","position":1,"cik":"0001560959","reported_name":"Horobin Joanna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-20T20:15:22.000Z","date":"2023-06-15","kind":"grant","planned":false,"acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this stock option shall vest in full upon the earlier to occur of (i) June 15, 2024 and (ii) the date of the next annual meeting of the Issuer's stockholders."}],"balance_after":12000,"derivative":{"exercise_price":27.67,"expiration_date":"2033-06-14","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0000899243-23-015963","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000089924323015963/doc4.xml","form_type":"4"}},{"id":2050563,"issuer":{"id":116415,"kind":"organization","name":"Vyant Bio, Inc.","symbol":"VYNT"},"owners":[{"id":36706,"kind":"person","name":"Horobin Joanna","position":1,"cik":"0001560959","reported_name":"Horobin Joanna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2023-01-19T16:30:13.000Z","date":"2023-01-17","kind":"grant","acquired":true,"shares":7526,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On January 17, 2023, the Reporting Person was granted 7,526 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units fully vest on January 17, 2024, so long as Reporting Person remains a director through that date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On January 17, 2023, the Reporting Person was granted 7,526 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units fully vest on January 17, 2024, so long as Reporting Person remains a director through that date."}],"balance_after":23123,"source":{"system":"sec-edgar","filing":"0001493152-23-001915","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1349929/000149315223001915/ownership.xml","form_type":"4"}},{"id":2134676,"issuer":{"id":116415,"kind":"organization","name":"Vyant Bio, Inc.","symbol":"VYNT"},"owners":[{"id":36706,"kind":"person","name":"Horobin Joanna","position":1,"cik":"0001560959","reported_name":"Horobin Joanna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2022-10-19T09:00:33.000Z","date":"2022-10-17","kind":"grant","acquired":true,"shares":14285,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On October 17, 2022, the Reporting Person was granted 14,285 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units fully vest on October 17, 2023, so long as Reporting Person remains a director though that date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On October 17, 2022, the Reporting Person was granted 14,285 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units fully vest on October 17, 2023, so long as Reporting Person remains a director though that date."}],"balance_after":77994,"source":{"system":"sec-edgar","filing":"0001493152-22-028718","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1349929/000149315222028718/ownership.xml","form_type":"4"}},{"id":2200035,"issuer":{"id":116415,"kind":"organization","name":"Vyant Bio, Inc.","symbol":"VYNT"},"owners":[{"id":36706,"kind":"person","name":"Horobin Joanna","position":1,"cik":"0001560959","reported_name":"Horobin Joanna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2022-07-29T17:01:22.000Z","date":"2022-07-18","kind":"grant","acquired":true,"shares":8092,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On July 18, 2022, the Reporting Person was granted 8,092 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units fully vest on July 18, 2023, so long as Reporting Person remains a director though that date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On July 18, 2022, the Reporting Person was granted 8,092 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units fully vest on July 18, 2023, so long as Reporting Person remains a director though that date."}],"balance_after":63709,"source":{"system":"sec-edgar","filing":"0001493152-22-020766","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1349929/000149315222020766/ownership.xml","form_type":"4"}},{"id":2223800,"issuer":{"id":1860,"kind":"organization","name":"Liquidia Corp","symbol":"LQDA"},"owners":[{"id":36706,"kind":"person","name":"Horobin Joanna","position":1,"cik":"0001560959","reported_name":"Horobin Joanna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2022-06-22T20:32:30.000Z","date":"2022-06-17","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 36 equal monthly installments and will become fully vested on June 17, 2025."}],"balance_after":20000,"derivative":{"exercise_price":4.86,"exercise_date":"2025-06-17","expiration_date":"2032-06-17","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001104659-22-073532","document":"tm2219055-5_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1560959/000110465922073532/tm2219055-5_4seq1.xml","form_type":"4"}},{"id":2230123,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":36706,"kind":"person","name":"Horobin Joanna","position":1,"cik":"0001560959","reported_name":"Horobin Joanna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-06-16T20:05:27.000Z","date":"2022-06-15","kind":"grant","acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this stock option shall vest in full upon the earlier to occur of (i) June 15, 2023 and (ii) the date of the next annual meeting of the Issuer's stockholders."}],"balance_after":12000,"derivative":{"exercise_price":14.18,"expiration_date":"2032-06-14","underlying":"Common Stock","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0000899243-22-022788","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000089924322022788/doc4.xml","form_type":"4"}},{"id":2294572,"issuer":{"id":116415,"kind":"organization","name":"Vyant Bio, Inc.","symbol":"VYNT"},"owners":[{"id":36706,"kind":"person","name":"Horobin Joanna","position":1,"cik":"0001560959","reported_name":"Horobin Joanna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2022-04-19T19:40:05.000Z","date":"2022-04-18","kind":"grant","acquired":true,"shares":6796,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On April 18, 2022, the Reporting Person was granted 6,796 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units fully vest on April 18, 2023, so long as Reporting Person remains a director though that date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On April 18, 2022, the Reporting Person was granted 6,796 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units fully vest on April 18, 2023, so long as Reporting Person remains a director though that date."}],"balance_after":55617,"source":{"system":"sec-edgar","filing":"0001493152-22-010480","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1349929/000149315222010480/ownership.xml","form_type":"4"}},{"id":2310971,"issuer":{"id":116415,"kind":"organization","name":"Vyant Bio, Inc.","symbol":"VYNT"},"owners":[{"id":36706,"kind":"person","name":"Horobin Joanna","position":1,"cik":"0001560959","reported_name":"Horobin Joanna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2022-04-01T16:30:45.000Z","date":"2022-03-30","kind":"grant","acquired":true,"shares":43478,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On March 30, 2022, the Reporting Person was granted 43,478 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units fully vest on March 30, 2023, so long as Reporting Person remains a director though that date."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"On March 30, 2022, the Reporting Person was granted 43,478 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units fully vest on March 30, 2023, so long as Reporting Person remains a director though that date."}],"balance_after":48821,"source":{"system":"sec-edgar","filing":"0001493152-22-008835","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1349929/000149315222008835/ownership.xml","form_type":"4"}},{"id":2429970,"issuer":{"id":116415,"kind":"organization","name":"Vyant Bio, Inc.","symbol":"VYNT"},"owners":[{"id":36706,"kind":"person","name":"Horobin Joanna","position":1,"cik":"0001560959","reported_name":"Horobin Joanna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock, $0.0001 par value","published_at":"2022-01-20T21:22:31.000Z","date":"2022-01-18","kind":"grant","acquired":true,"shares":5343,"price":1.31,"value":6999.33,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On January 18, 2022, the Reporting Person was granted 5,343 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units fully vest on January 17, 2023, so long as Reporting Person remains a director though that date."}],"balance_after":5343,"source":{"system":"sec-edgar","filing":"0001493152-22-001791","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1349929/000149315222001791/ownership.xml","form_type":"4"}},{"id":2583125,"issuer":{"id":1860,"kind":"organization","name":"Liquidia Corp","symbol":"LQDA"},"owners":[{"id":36706,"kind":"person","name":"Horobin Joanna","position":1,"cik":"0001560959","reported_name":"Horobin Joanna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-09-01T21:25:10.000Z","date":"2021-08-20","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 36 equal monthly installments and will become fully vested on August 20, 2024."}],"balance_after":20000,"derivative":{"exercise_price":2.59,"exercise_date":"2024-08-20","expiration_date":"2031-08-20","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001104659-21-112110","document":"tm2126786-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1560959/000110465921112110/tm2126786-2_4seq1.xml","form_type":"4"}},{"id":2664099,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":36706,"kind":"person","name":"Horobin Joanna","position":1,"cik":"0001560959","reported_name":"Horobin Joanna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2021-06-17T20:49:23.000Z","date":"2021-06-16","kind":"grant","acquired":true,"shares":20063,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this stock option shall vest in full upon the earlier to occur of (i) June 16, 2022 and (ii) the date of the next annual meeting of the Issuer's stockholders."}],"balance_after":20063,"derivative":{"exercise_price":49.1,"expiration_date":"2031-06-15","underlying":"Common Stock","underlying_shares":20063},"source":{"system":"sec-edgar","filing":"0000899243-21-024445","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000089924321024445/doc4.xml","form_type":"4"}},{"id":2763504,"issuer":{"id":116415,"kind":"organization","name":"Vyant Bio, Inc.","symbol":"VYNT"},"owners":[{"id":36706,"kind":"person","name":"Horobin Joanna","position":1,"cik":"0001560959","reported_name":"Horobin Joanna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2021-04-01T21:32:36.000Z","date":"2021-03-30","kind":"grant","acquired":true,"shares":13015,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":13015,"derivative":{"exercise_price":4.61,"exercise_date":"2021-03-30","expiration_date":"2031-03-30","underlying":"Common Stock","underlying_shares":13015},"source":{"system":"sec-edgar","filing":"0001493152-21-007816","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1349929/000149315221007816/ownership.xml","form_type":"4"}},{"id":2763503,"issuer":{"id":116415,"kind":"organization","name":"Vyant Bio, Inc.","symbol":"VYNT"},"owners":[{"id":36706,"kind":"person","name":"Horobin Joanna","position":1,"cik":"0001560959","reported_name":"Horobin Joanna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock option (right to buy)","published_at":"2021-04-01T21:32:36.000Z","date":"2021-03-30","kind":"other","acquired":true,"shares":5068,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"Pursuant to that certain Agreement and Plan of Merger, dated as of August 21, 2020, as amended, by and among Cancer Genetics, Inc. now known as Vyant Bio, Inc. (\"Issuer\"), CGI Acquisition, Inc., a Minnesota corporation and a wholly-owned subsidiary of Issuer (\"Merger Sub\") and StemoniX, Inc., a Minnesota corporation (\"StemoniX\") (the \"Merger Agreement\"), Reporting Person received options to purchase shares of Common Stock of the Issuer in exchange for options to purchase shares of StemoniX common stock, $0.0001 owned prior to the merger. These options are fully vested."}],"balance_after":5068,"derivative":{"exercise_price":1.56,"exercise_date":"2021-03-30","expiration_date":"2030-12-01","underlying":"Common Stock","underlying_shares":5068},"source":{"system":"sec-edgar","filing":"0001493152-21-007816","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1349929/000149315221007816/ownership.xml","form_type":"4"}},{"id":2770281,"issuer":{"id":1860,"kind":"organization","name":"Liquidia Corp","symbol":"LQDA"},"owners":[{"id":36706,"kind":"person","name":"Horobin Joanna","position":1,"cik":"0001560959","reported_name":"Horobin Joanna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2021-03-26T20:05:26.000Z","date":"2021-03-24","kind":"grant","acquired":true,"shares":35872,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests quarterly during 2021, with 25% of the option shares vesting on the date of grant, and 25% of the option shares vesting on each of June 30, 2021, September 30, 2021 and December 31, 2021, becoming fully vested on December 31, 2021."}],"balance_after":35872,"derivative":{"exercise_price":2.51,"expiration_date":"2031-03-24","underlying":"Common Stock","underlying_shares":35872},"source":{"system":"sec-edgar","filing":"0001104659-21-042423","document":"tm2111007-2_4seq1.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1560959/000110465921042423/tm2111007-2_4seq1.xml","form_type":"4"}},{"id":3050060,"issuer":{"id":3545,"kind":"organization","name":"Kymera Therapeutics, Inc.","symbol":"KYMR"},"owners":[{"id":36706,"kind":"person","name":"Horobin Joanna","position":1,"cik":"0001560959","reported_name":"Horobin Joanna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-08-21T22:22:31.000Z","date":"2020-08-20","kind":"grant","acquired":true,"shares":40127,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares subject to this option shall vest in thirty-six (36) equal monthly installments over three (3) years commencing on the date of the Registration Statement Effectiveness."}],"balance_after":40127,"derivative":{"exercise_price":20,"expiration_date":"2030-08-19","underlying":"Common Stock","underlying_shares":40127},"source":{"system":"sec-edgar","filing":"0000899243-20-023228","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1815442/000089924320023228/doc4.xml","form_type":"4"}},{"id":3101700,"issuer":{"id":145051,"kind":"organization","name":"Liquidia Technologies Inc","symbol":"LQDA"},"owners":[{"id":36706,"kind":"person","name":"Horobin Joanna","position":1,"cik":"0001560959","reported_name":"Horobin Joanna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2020-06-23T16:30:29.000Z","date":"2020-06-22","kind":"grant","acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 36 equal monthly installments, becoming fully vested on June 22, 2023."}],"balance_after":20000,"derivative":{"exercise_price":10.97,"exercise_date":"2020-07-22","expiration_date":"2030-06-22","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001104659-20-076074","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1330436/000110465920076074/a4.xml","form_type":"4"}},{"id":3416048,"issuer":{"id":145051,"kind":"organization","name":"Liquidia Technologies Inc","symbol":"LQDA"},"owners":[{"id":36706,"kind":"person","name":"Horobin Joanna","position":1,"cik":"0001560959","reported_name":"Horobin Joanna","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Non-Qualified Stock Option (right to buy)","published_at":"2019-09-12T17:00:34.000Z","date":"2019-09-11","kind":"grant","acquired":true,"shares":15000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 36 equal monthly installments, becoming fully vested on September 11, 2022."}],"balance_after":15000,"derivative":{"exercise_price":4.22,"exercise_date":"2019-10-11","expiration_date":"2029-09-11","underlying":"Common Stock","underlying_shares":15000},"source":{"system":"sec-edgar","filing":"0001104659-19-049984","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1330436/000110465919049984/a4.xml","form_type":"4"}},{"id":3463864,"issuer":{"id":110652,"kind":"organization","name":"Aceragen, Inc.","symbol":"ACGN"},"owners":[{"id":36706,"kind":"person","name":"Horobin Joanna","position":1,"cik":"0001560959","reported_name":"Horobin Joanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-07-11T17:18:28.000Z","date":"2019-07-09","kind":"grant","acquired":true,"shares":45500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option award was granted under the Issuer's 2013 Stock Incentive Plan. The stock option vests and becomes exercisable over a four-year period commencing on July 9, 2019. Twenty-five percent (25%) of the stock option vests and becomes exercisable on July 9, 2020 (first anniversary of the date of grant) and the balance vests in twelve equal quarterly installments over the remaining three years of the four-year period, subject to continued service with the Issuer."}],"balance_after":45500,"derivative":{"exercise_price":2.52,"expiration_date":"2029-07-09","underlying":"Common Stock","underlying_shares":45500},"source":{"system":"sec-edgar","filing":"0001179110-19-008596","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/861838/000117911019008596/edgar.xml","form_type":"4"}},{"id":3702558,"issuer":{"id":110652,"kind":"organization","name":"Aceragen, Inc.","symbol":"ACGN"},"owners":[{"id":36706,"kind":"person","name":"Horobin Joanna","position":1,"cik":"0001560959","reported_name":"Horobin Joanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option (Right to Buy)","published_at":"2019-01-07T20:24:53.000Z","date":"2019-01-03","kind":"grant","acquired":true,"shares":45500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The stock option award was granted under the Issuer's 2013 Stock Incentive Plan. The stock option vests and becomes exercisable over a four-year period commencing on January 3, 2019. Twenty-five percent (25%) of the stock option vests and becomes exercisable on January 3, 2020 (first anniversary of the date of grant) and the balance vests in twelve equal quarterly installments over the remaining three years of the four-year period, subject to continued service with the Issuer."}],"balance_after":45500,"derivative":{"exercise_price":3.14,"expiration_date":"2029-01-03","underlying":"Common Stock","underlying_shares":45500},"source":{"system":"sec-edgar","filing":"0001179110-19-000534","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/861838/000117911019000534/edgar.xml","form_type":"4"}},{"id":3702557,"issuer":{"id":110652,"kind":"organization","name":"Aceragen, Inc.","symbol":"ACGN"},"owners":[{"id":36706,"kind":"person","name":"Horobin Joanna","position":1,"cik":"0001560959","reported_name":"Horobin Joanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2019-01-07T20:24:53.000Z","date":"2019-01-03","kind":"grant","acquired":true,"shares":18100,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award granted under the Issuer's 2013 Stock Incentive Plan. Each RSU represents a right to receive one share of Issuer common stock. The RSU award vests over a four-year period commencing on January 3, 2019. Twenty-five percent (25%) of the shares subject to the RSU award shall vest on each one-year anniversary of the grant date of the award."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Securities beneficially owned totaling 20,144 includes 2,044 shares of Issuer common stock owned and 18,100 of unvested RSU's held by the reporting person."}],"balance_after":20144,"source":{"system":"sec-edgar","filing":"0001179110-19-000534","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/861838/000117911019000534/edgar.xml","form_type":"4"}},{"id":3723903,"issuer":{"id":110652,"kind":"organization","name":"Aceragen, Inc.","symbol":"ACGN"},"owners":[{"id":36706,"kind":"person","name":"Horobin Joanna","position":1,"cik":"0001560959","reported_name":"Horobin Joanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Common Stock","published_at":"2018-12-20T17:27:37.000Z","date":"2018-12-20","kind":"purchase","acquired":true,"shares":300,"price":3.45,"value":1035.0,"ownership":{"direct":true},"balance_after":2044,"source":{"system":"sec-edgar","filing":"0001179110-18-014194","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/861838/000117911018014194/edgar.xml","form_type":"4"}},{"id":3843944,"issuer":{"id":110652,"kind":"organization","name":"Aceragen, Inc.","symbol":"ACGN"},"owners":[{"id":36706,"kind":"person","name":"Horobin Joanna","position":1,"cik":"0001560959","reported_name":"Horobin Joanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2018-08-15T16:27:40.000Z","date":"2018-08-13","kind":"grant","acquired":true,"shares":32500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted under the Company's 2013 Stock Incentive Plan. The option vests with respect to 25% of the underlying shares on the first anniversary of the date of grant and the balance of the underlying shares vest in twelve equal quarterly installments following the first anniversary of the date of grant."}],"balance_after":32500,"derivative":{"exercise_price":7.39,"expiration_date":"2028-08-13","underlying":"Common Stock","underlying_shares":32500},"source":{"system":"sec-edgar","filing":"0001104659-18-052285","document":"a4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/861838/000110465918052285/a4.xml","form_type":"4"}},{"id":4106075,"issuer":{"id":110652,"kind":"organization","name":"Aceragen, Inc.","symbol":"ACGN"},"owners":[{"id":36706,"kind":"person","name":"Horobin Joanna","position":1,"cik":"0001560959","reported_name":"Horobin Joanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2018-01-05T16:21:39.000Z","date":"2018-01-03","kind":"grant","acquired":true,"shares":270000,"price":2.24,"value":604800.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted under the Company's 2013 Stock Incentive Plan. The options vest with respect to 25% of the underlying shares on the first anniversary of the date of grant and the balance of the underlying shares vest in twelve equal quarterly installments following the first anniversary of the date of grant."}],"balance_after":270000,"derivative":{"exercise_price":2.24,"expiration_date":"2028-01-03","underlying":"Common Stock","underlying_shares":270000},"source":{"system":"sec-edgar","filing":"0001179110-18-000589","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/861838/000117911018000589/edgar.xml","form_type":"4"}},{"id":4496989,"issuer":{"id":110652,"kind":"organization","name":"Aceragen, Inc.","symbol":"ACGN"},"owners":[{"id":36706,"kind":"person","name":"Horobin Joanna","position":1,"cik":"0001560959","reported_name":"Horobin Joanna","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Medical Officer"}}],"security":"Stock Option","published_at":"2017-01-06T16:23:43.000Z","date":"2017-01-03","kind":"grant","acquired":true,"shares":185000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"This option was granted under the Company's 2013 Stock Incentive Plan.  The options vest with respect to 25% of the underlying shares on the first anniversary of the date of grant and the balance of the underlying shares vest in twelve equal quarterly installments following the first anniversary of the date of grant."}],"balance_after":185000,"derivative":{"exercise_price":1.59,"expiration_date":"2027-01-03","underlying":"Common Stock","underlying_shares":185000},"source":{"system":"sec-edgar","filing":"0001179110-17-000644","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/861838/000117911017000644/edgar.xml","form_type":"4"}}]}